{ "Mild Cognitive Impairment Study: Stem Cell Therapy and Brain-Computer Interface", "This study is looking at new ways to help people with Mild Cognitive Impairment (MCI), which is an early stage of memory or thinking problems. It's testing if early detection in the community, along with treatments like stem cell therapy and a wearable brain-computer interface (BCI) device, can improve cognitive function and slow down the progression to dementia. The study aims to enroll 600 participants aged 55 and older who live in U.S. urban or suburban areas and have suspected or confirmed MCI. You cannot have a formal dementia diagnosis already. Success will be measured by changes in memory and thinking scores (MoCA score) and how many people progress to dementia over time. The current recruitment status is unclear.", "design": "This is a large, randomized, double-blind, placebo-controlled study involving 600 participants. This means participants are randomly assigned to different groups, and neither you nor the study staff will know which treatment you are receiving.", "commitments": "You would participate in structured wellness programs, potentially use a wearable brain-computer interface device, and might receive stem cell therapy or a placebo. You would have cognitive assessments at baseline, 6 months, 1 year, and annually for up to 5 years.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be followed for up to 5 years, with annual assessments to track cognitive function and progression to dementia.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.